Abstract
AIM: To analyze the characteristics of the small intestine of patients with gastrointestinal disorders by capsule endoscopy.
METHODS: Fifty-three patients who underwent MiroCam capsule endoscopy from August 2010 to August 2011 were included in the study. According to clinical data, the patients were classified as having obscure gastrointestinal bleeding, suspected functional gastrointestinal disease, abdominal pain, diarrhea, and abdominal distension. The characteristics of the normal or abnormal small bowel were analyzed.
RESULTS: Of 53 patients, one failed capsule endoscopy due to the absence of signal, and one could not successfully complete the examination procedure for personal reason. The capsule endoscope reached the colon in the remaining 51 cases (96.22%). The average time for the passage of the capsule endoscope to the stomach and small intestine is 69.78 and 513.25 min, respectively. Capsule endoscopy revealed abnormal changes in 48 cases, and the positive rate is 90.57%. For all 51 patients with suspected small bowel disease, the overall positive diagnosis rate of intestinal lesions was 92.15% (47/51), and that of jejunal and ileal lesions was 52.94%, including 12 cases of non-specific inflammation (1 patient diagnosed with Crohn's disease), 3 cases of polyps, 3 cases of unknown mass, 1 case of hyperplasia of lymphoid follicles, 7 cases of intestinal lymphangiectasia, and 1 case of hookworm disease. In addition, 1 case of of reflux esophagitis, 26 cases of chronic gastritis, 7 cases of erosive gastritis, 3 cases of stomach polyps, 5 cases of colon polyps, 3 cases of colitis, and 2 cases of colon melanosis were found. Capsules were removed from the body naturally, and no complications such as obstruction occurred.
CONCLUSION: MiroCam capsule endoscopy is a safe and non-invasive means of revealing small intestinal lesions.
Collapse